{"title":"Extremely premature infant care: Reasonable progress or therapeutic fury?","authors":"Joseph W. Kaempf","doi":"10.1016/j.siny.2026.101714","DOIUrl":"10.1016/j.siny.2026.101714","url":null,"abstract":"<div><div>Application of palliative comfort care versus neonatal intensive care for extremely premature births is a judgment fraught with uncertainty and risk, principally for the pregnant woman and family. Survival and good health are possible, but suffering, chronic health issues, and socio-economic inequities are burdensome to families. Survival rates of infants born at 22, 23, and 24 weeks’ gestation are increasing, but morbidity rates and long-term neurodevelopmental impairments are substantial and not improving. Outcomes acceptable to some pregnant women and families are not acceptable to others. Autonomy of pregnant women contrasted with the rights of the fetus and infant are affected by culture, religion, technology, and powerfully persuaded by physicians who possess conflicts-of-interest related to career goals, income, and research priorities. Interventions related to extreme prematurity care such as cesarean deliveries create serious health risks for pregnant women. Intensive care of extremely premature infants is expensive, and lost opportunity costs for families and society are under-appreciated. Physicians should resist dogmatic positions tethered to non-rigorous evidence and technology. Physicians best serve pregnant women by listening to their concerns and preferences, objectively reviewing clinical outcomes, and by avoiding care options presented as restrictive protocols, or wide-open menus. The legitimate zone of parental discretion embraces value pluralistic shared decision-making and informed consent. This principle is unequivocally endorsed by the American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Because there is no unifying cultural, religious, or bioethical ethos, we should embrace shared decision-making recognizing the inherent contingencies and disagreements of extreme prematurity.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101714"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The case for inhaled nitric oxide use in preterm infants","authors":"Adrianne R. Bischoff","doi":"10.1016/j.siny.2026.101721","DOIUrl":"10.1016/j.siny.2026.101721","url":null,"abstract":"","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101721"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147516213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Critical thinking in red blood cell transfusion decisions: Donor, product, recipient, and outcomes","authors":"Cassandra D. Josephson , Ravi M. Patel","doi":"10.1016/j.siny.2026.101717","DOIUrl":"10.1016/j.siny.2026.101717","url":null,"abstract":"<div><div>Red blood cell (RBC) transfusion is a common and potentially lifesaving intervention in neonatal care, particularly for very low birth weight (VLBW) infants. Transfusion decisions are often guided by hemoglobin thresholds; however, these surrogate markers may incompletely capture the complex physiologic, immunologic, and developmental factors that influence transfusion benefit and risk. This review presents a critical thinking framework for neonatal RBC transfusion decision-making that integrates donor characteristics, blood product attributes, recipient vulnerability, and clinical outcomes. We summarize infectious and non-infectious risks of RBC transfusion. Contemporary strategies to mitigate transfusion-transmitted cytomegalovirus (CMV), including leukoreduction and CMV-seronegative donor selection, are discussed in the context of evidence demonstrating extremely low residual risk and maternal breast milk as the primary source of postnatal infection in VLBW infants. We also note variability in blood banking practices and clinical implications. Emerging physiological data suggests that storage-related changes, particularly following irradiation, may affect regional tissue oxygenation in preterm infants, although the clinical significance is uncertain. Evidence from randomized trials does not support routine use of fresh RBCs to improve major neonatal outcomes, underscoring the need to move beyond storage age alone when evaluating transfusion practices. Finally, we highlight future research directions, including vein-to-vein studies linking donor and product characteristics to recipient outcomes, and emphasize the importance of close collaboration between neonatologists and transfusion medicine specialists to optimize neonatal patient blood management and improve outcomes in this highly vulnerable population.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101717"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147934974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Matthew A. Saxonhouse , Cassandra Josephson , Robin Ohls , Ravi Patel
{"title":"Packed red blood cell transfusion in the very low birth weight infant: Aggressive, conservative, or neither?","authors":"Matthew A. Saxonhouse , Cassandra Josephson , Robin Ohls , Ravi Patel","doi":"10.1016/j.siny.2026.101719","DOIUrl":"10.1016/j.siny.2026.101719","url":null,"abstract":"","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101719"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147460711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The case against use of inhaled nitric oxide for hypoxic respiratory failure in the premature neonate","authors":"Amir M. Khan","doi":"10.1016/j.siny.2026.101722","DOIUrl":"10.1016/j.siny.2026.101722","url":null,"abstract":"","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101722"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147500439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Human milk fortification in preterm infants: Navigating evidence, practice, and controversy","authors":"Amy B. Hair , Brenda B. Poindexter","doi":"10.1016/j.siny.2026.101711","DOIUrl":"10.1016/j.siny.2026.101711","url":null,"abstract":"<div><div>Human milk is universally recognized as the optimal source of nutrition for preterm infants, providing immunologic, bioactive, and enzymatic components that provide health benefits and are associated with decreased morbidities of prematurity. However, fortification of both maternal breast milk (MBM) and donor breast milk (DBM) is needed to meet the elevated metabolic needs and nutrient requirements of preterm infants. This narrative review, reflecting the content presented, audience questions, and the roundtable discussion from the 2025 Neonatal Insights Conference, synthesizes current evidence and literature to evaluate the rationale, composition, and outcomes associated with differing fortification approaches. Randomized controlled trials evaluating fortifier type remain limited to small studies with high MBM usage. Future research must focus on trials evaluating fortifier type in infants who receive MBM and those that receive primarily DBM. Advancing fortification practices requires individualized nutrition planning and maternal breastfeeding support to achieve optimal growth and developmental trajectories for preterm infants.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101711"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147724399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Combined use of erythropoiesis-stimulating agents and transfusion guidelines in NICU infants","authors":"Robin K. Ohls","doi":"10.1016/j.siny.2026.101718","DOIUrl":"10.1016/j.siny.2026.101718","url":null,"abstract":"<div><div>Red blood cell transfusions from adult donors can be lifesaving for neonates with severe anemia or acute massive hemorrhage but can be associated with specific and significant risks. Infectious transmission, acute lung injury, and circulatory overload are well known risks and are part of blood transfusion informed consent. Less well-described, but more common, are the risks that occur when transfusing the smallest and most immature neonates, those less than 1000 g. Repeated adult red cell transfusions may worsen inflammatory conditions, such as pulmonary inflammation, and they can increase the incidence and severity of retinopathy of prematurity and neurodevelopmental delay. In this review, we will provide an overview of neonatal transfusion stewardship including instituting both non-pharmacological transfusion-avoidance techniques and pharmacologic strategies to reduce transfusion rates. Erythropoiesis-stimulating agents like erythropoietin and darbepoetin further reduce and can eliminate the need for a transfusion. Instituting non-pharmacologic and pharmacologic strategies will increase the number of NICU infants who remain transfusion free, even those born weighing less than 1000 g.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101718"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147494479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fortification of human milk for feeding preterm infants: What is the ideal strategy?","authors":"Fernando Moya","doi":"10.1016/j.siny.2026.101710","DOIUrl":"10.1016/j.siny.2026.101710","url":null,"abstract":"<div><div>Promoting optimal growth in preterm infants is of paramount importance. Multiple reports have associated better growth during their Neonatal Intensive Care Unit (NICU) stay with improved neurodevelopmental outcome and a lesser risk of certain morbidities. Nowadays, most preterm infants receive human milk (HM) feedings, either mother's own or donor milk. Widespread use of HM to feed preterm infants has contributed to a decrease in complications like necrotizing enterocolitis. This notwithstanding, HM often does not provide sufficient protein and other nutrients to promote adequate growth in these infants and, therefore, must be fortified with specially designed human milk fortifiers of human or bovine origin. These provide added amounts of protein, minerals like sodium, calcium, and phosphorus as well as vitamins and other micronutrients. Which fortification strategy, i.e. type of fortifier, timing of fortification, must be used to promote optimal growth and neurodevelopment is still a matter of debate. The following articles by the well-recognized experts in neonatal nutrition, Drs. Amy Hair and Brenda Poindexter, will describe alternate strategies to fortify HM and their potential benefits, and are a reflection of the scholarly discussions held during the 2025 Neonatal Insights: Best Evidence and Practice in Clinical Neonatology Conference.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101710"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147379302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Approaches to red blood cell transfusion for the very low birth weight infant","authors":"Ravi M. Patel","doi":"10.1016/j.siny.2026.101716","DOIUrl":"10.1016/j.siny.2026.101716","url":null,"abstract":"","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101716"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}